D
Theratechnologies Inc.
THTX
$1.49
$0.08015.68%
D
Sell
2/27/2025Upgraded
Theratechnologies Inc. (THTX) was upgraded to D- from E+ on 2/27/2025 due to an increase in the solvency index, total return index and volatility index.
Theratechnologies Inc. (THTX) was upgraded to D- from E+ on 2/27/2025 due to an increase in the solvency index, total return index and volatility index.
E
Sell
3/14/2023Downgrade
Theratechnologies Inc. (THTX) was downgraded to E+ from D- on 3/14/2023 due to a decline in the growth index, solvency index and total return index. Operating cash flow declined 589.3% from -$1.2M to -$8.24M, the quick ratio declined from 0.64 to 0.41, and debt to equity increased from -3.59 to -2.89.
Theratechnologies Inc. (THTX) was downgraded to E+ from D- on 3/14/2023 due to a decline in the growth index, solvency index and total return index. Operating cash flow declined 589.3% from -$1.2M to -$8.24M, the quick ratio declined from 0.64 to 0.41, and debt to equity increased from -3.59 to -2.89.
D
Sell
2/23/2023Upgraded
Theratechnologies Inc. (THTX) was upgraded to D- from E+ on 02/23/2023.
Theratechnologies Inc. (THTX) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Theratechnologies Inc. (THTX) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
Theratechnologies Inc. (THTX) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell
2/2/2023Downgrade
Theratechnologies Inc. (THTX) was downgraded to D- from D on 2/2/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.91 to 0.64, and debt to equity increased from -4.78 to -3.59.
Theratechnologies Inc. (THTX) was downgraded to D- from D on 2/2/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.91 to 0.64, and debt to equity increased from -4.78 to -3.59.
D
Sell
5/16/2022Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 05/16/2022.
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
E
Sell
5/1/2022Downgrade
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 05/01/2022.
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 04/21/2022.
Theratechnologies Inc. (THTX) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 4/20/2022 due to a major decline in the total return index, solvency index and volatility index. Debt to equity increased from 3.08 to 5.43, and the quick ratio declined from 1.2 to 1.15.
Theratechnologies Inc. (THTX) was downgraded to E+ from D on 4/20/2022 due to a major decline in the total return index, solvency index and volatility index. Debt to equity increased from 3.08 to 5.43, and the quick ratio declined from 1.2 to 1.15.
D
Sell
11/23/2021Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
Theratechnologies Inc. (THTX) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Theratechnologies Inc. (THTX) was downgraded to D- from D on 11/08/2021.
Theratechnologies Inc. (THTX) was downgraded to D- from D on 11/08/2021.
D
Sell
3/3/2021Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from D- on 3/3/2021 due to an increase in the total return index, growth index and volatility index. Total revenue increased 36.12% from $14.05M to $19.12M, EBIT increased 31.16% from -$5.97M to -$4.11M, and earnings per share increased from -$0.0879 to -$0.07.
Theratechnologies Inc. (THTX) was upgraded to D from D- on 3/3/2021 due to an increase in the total return index, growth index and volatility index. Total revenue increased 36.12% from $14.05M to $19.12M, EBIT increased 31.16% from -$5.97M to -$4.11M, and earnings per share increased from -$0.0879 to -$0.07.
D
Sell
5/20/2020Downgrade
Theratechnologies Inc. (THTX) was downgraded to D- from D on 5/20/2020 due to a large decline in the growth index, efficiency index and total return index.
Theratechnologies Inc. (THTX) was downgraded to D- from D on 5/20/2020 due to a large decline in the growth index, efficiency index and total return index.
D
Sell
4/15/2020Upgraded
Theratechnologies Inc. (THTX) was upgraded to D from D- on 4/15/2020 due to a noticeable increase in the growth index and valuation index. EBIT increased 37.15% from -$5.4M to -$3.39M, and earnings per share increased from -$0.0839 to -$0.06.
Theratechnologies Inc. (THTX) was upgraded to D from D- on 4/15/2020 due to a noticeable increase in the growth index and valuation index. EBIT increased 37.15% from -$5.4M to -$3.39M, and earnings per share increased from -$0.0839 to -$0.06.
D
Sell
3/20/2020Downgrade
Theratechnologies Inc. (THTX) was downgraded to D- from D on 3/20/2020 due to a substantial decline in the total return index, volatility index and growth index. EBIT declined 744.6% from -$639 to -$5.4M, earnings per share declined from -$0.0213 to -$0.0839, and operating cash flow declined 106.5% from $4.56M to -$296.
Theratechnologies Inc. (THTX) was downgraded to D- from D on 3/20/2020 due to a substantial decline in the total return index, volatility index and growth index. EBIT declined 744.6% from -$639 to -$5.4M, earnings per share declined from -$0.0213 to -$0.0839, and operating cash flow declined 106.5% from $4.56M to -$296.
D
Sell
5/1/2019Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 5/1/2019 due to a decline in the total return index and volatility index.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 5/1/2019 due to a decline in the total return index and volatility index.
D
Sell
4/8/2019Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 4/8/2019 due to a noticeable increase in the growth index. Total revenue increased 7.92% from $13.99M to $15.1M.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 4/8/2019 due to a noticeable increase in the growth index. Total revenue increased 7.92% from $13.99M to $15.1M.
D
Sell
2/25/2019Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 2/25/2019 due to a noticeable decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.0036 to -$0.0134, net income declined 452.82% from $280.2 to -$988.6, and EBIT declined 23.26% from $81.7 to $62.7.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 2/25/2019 due to a noticeable decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.0036 to -$0.0134, net income declined 452.82% from $280.2 to -$988.6, and EBIT declined 23.26% from $81.7 to $62.7.
D
Sell
10/5/2018Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 10/5/2018 due to an increase in the growth index, efficiency index and valuation index. Total capital increased 178.85% from $30.2M to $84.21M, operating cash flow increased 127.33% from -$3.21M to $878.7, and net income increased 114.63% from -$1.92M to $280.2.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 10/5/2018 due to an increase in the growth index, efficiency index and valuation index. Total capital increased 178.85% from $30.2M to $84.21M, operating cash flow increased 127.33% from -$3.21M to $878.7, and net income increased 114.63% from -$1.92M to $280.2.
D
Sell
9/6/2018Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 9/6/2018 due to a large decline in the total return index and volatility index.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 9/6/2018 due to a large decline in the total return index and volatility index.
D
Sell
7/23/2018Downgrade
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 7/23/2018 due to a noticeable decline in the total return index and volatility index.
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 7/23/2018 due to a noticeable decline in the total return index and volatility index.
C
Hold
7/6/2018Upgraded
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 7/6/2018 due to an increase in the efficiency index and volatility index. Net income increased 8.2% from -$2.09M to -$1.92M.
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 7/6/2018 due to an increase in the efficiency index and volatility index. Net income increased 8.2% from -$2.09M to -$1.92M.
D
Sell
4/6/2018Downgrade
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 4/6/2018 due to a decline in the solvency index, efficiency index and total return index. Total capital declined 5.68% from $33.46M to $31.56M, and the quick ratio declined from 1.15 to 1.12.
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 4/6/2018 due to a decline in the solvency index, efficiency index and total return index. Total capital declined 5.68% from $33.46M to $31.56M, and the quick ratio declined from 1.15 to 1.12.
C
Hold
3/22/2018Upgraded
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 3/22/2018 due to a major increase in the total return index.
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 3/22/2018 due to a major increase in the total return index.
D
Sell
3/7/2018Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 3/7/2018 due to an increase in the total return index.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 3/7/2018 due to an increase in the total return index.
D
Sell
1/25/2018Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 1/25/2018 due to a decline in the volatility index.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 1/25/2018 due to a decline in the volatility index.
D
Sell
1/4/2018Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 1/4/2018 due to an increase in the total return index.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 1/4/2018 due to an increase in the total return index.
D
Sell
12/20/2017Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 12/20/2017 due to a substantial decline in the total return index.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 12/20/2017 due to a substantial decline in the total return index.
D
Sell
11/1/2017Downgrade
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 11/1/2017 due to a major decline in the total return index.
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 11/1/2017 due to a major decline in the total return index.
C
Hold
10/6/2017Upgraded
Theratechnologies Inc. (THERF) was upgraded to C- from D on 10/6/2017 due to a major increase in the solvency index, efficiency index and growth index. Earnings per share increased from -$0.0926 to -$0.0301, net income increased 66.85% from -$6.76M to -$2.24M, and EBIT increased 23.51% from -$2.94M to -$2.25M.
Theratechnologies Inc. (THERF) was upgraded to C- from D on 10/6/2017 due to a major increase in the solvency index, efficiency index and growth index. Earnings per share increased from -$0.0926 to -$0.0301, net income increased 66.85% from -$6.76M to -$2.24M, and EBIT increased 23.51% from -$2.94M to -$2.25M.
D
Sell
4/7/2017Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from C- on 4/7/2017 due to a decline in the efficiency index and volatility index. Net income declined 1,400.31% from $130.5 to -$1.7M.
Theratechnologies Inc. (THERF) was downgraded to D from C- on 4/7/2017 due to a decline in the efficiency index and volatility index. Net income declined 1,400.31% from $130.5 to -$1.7M.
C
Hold
2/27/2017Upgraded
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 2/27/2017 due to an increase in the total return index.
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 2/27/2017 due to an increase in the total return index.
D
Sell
2/10/2017Downgrade
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 2/10/2017 due to a large decline in the growth index, total return index and efficiency index. Net income declined 80.94% from $684.2 to $130.4, and earnings per share declined from $0.0077 to $0.002.
Theratechnologies Inc. (THERF) was downgraded to D+ from C- on 2/10/2017 due to a large decline in the growth index, total return index and efficiency index. Net income declined 80.94% from $684.2 to $130.4, and earnings per share declined from $0.0077 to $0.002.
C
Hold
7/7/2016Downgrade
Theratechnologies Inc. (THERF) was downgraded to C- from C on 7/7/2016 due to a decline in the efficiency index and valuation index. Net income declined 248.05% from -$110.1 to -$383.2.
Theratechnologies Inc. (THERF) was downgraded to C- from C on 7/7/2016 due to a decline in the efficiency index and valuation index. Net income declined 248.05% from -$110.1 to -$383.2.
C
Hold
4/28/2016Upgraded
Theratechnologies Inc. (THERF) was upgraded to C from C- on 4/28/2016 due to a large increase in the total return index.
Theratechnologies Inc. (THERF) was upgraded to C from C- on 4/28/2016 due to a large increase in the total return index.
C
Hold
4/22/2016Upgraded
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 4/22/2016 due to a significant increase in the total return index and volatility index.
Theratechnologies Inc. (THERF) was upgraded to C- from D+ on 4/22/2016 due to a significant increase in the total return index and volatility index.
D
Sell
4/1/2016Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 4/1/2016 due to an increase in the solvency index, efficiency index and valuation index.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 4/1/2016 due to an increase in the solvency index, efficiency index and valuation index.
D
Sell
3/11/2016Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from C on 3/11/2016 due to a significant decline in the volatility index, valuation index and total return index.
Theratechnologies Inc. (THERF) was downgraded to D from C on 3/11/2016 due to a significant decline in the volatility index, valuation index and total return index.
C
Hold
2/26/2016Upgraded
Theratechnologies Inc. (THERF) was upgraded to C from D+ on 2/26/2016 due to a noticeable increase in the efficiency index, valuation index and solvency index. Total capital increased 91.35% from $14.48M to $27.7M, and the quick ratio increased from 1.1 to 1.18.
Theratechnologies Inc. (THERF) was upgraded to C from D+ on 2/26/2016 due to a noticeable increase in the efficiency index, valuation index and solvency index. Total capital increased 91.35% from $14.48M to $27.7M, and the quick ratio increased from 1.1 to 1.18.
D
Sell
10/2/2015Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 10/2/2015 due to a substantial increase in the total return index, growth index and solvency index. The quick ratio increased from 0.48 to 1.1, earnings per share increased from $0.0081 to $0.0148, and operating cash flow increased 77.58% from $893.4 to $1.59M.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 10/2/2015 due to a substantial increase in the total return index, growth index and solvency index. The quick ratio increased from 0.48 to 1.1, earnings per share increased from $0.0081 to $0.0148, and operating cash flow increased 77.58% from $893.4 to $1.59M.
D
Sell
7/30/2015Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 7/30/2015 due to a decline in the efficiency index and valuation index.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 7/30/2015 due to a decline in the efficiency index and valuation index.
D
Sell
7/15/2015Upgraded
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 7/15/2015 due to a significant increase in the growth index, volatility index and total return index. Total revenue increased 54.52% from $3.81M to $5.88M, and operating cash flow increased 49.02% from $599.5 to $893.4.
Theratechnologies Inc. (THERF) was upgraded to D+ from D on 7/15/2015 due to a significant increase in the growth index, volatility index and total return index. Total revenue increased 54.52% from $3.81M to $5.88M, and operating cash flow increased 49.02% from $599.5 to $893.4.
D
Sell
3/11/2014Downgrade
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 3/11/2014 due to a large decline in the growth index, efficiency index and valuation index. Operating cash flow declined 327.91% from $592.6 to -$1.35M, total revenue declined 42.86% from $2.1M to $1.2M, and total capital declined 12.57% from $20.01M to $17.49M.
Theratechnologies Inc. (THERF) was downgraded to D from D+ on 3/11/2014 due to a large decline in the growth index, efficiency index and valuation index. Operating cash flow declined 327.91% from $592.6 to -$1.35M, total revenue declined 42.86% from $2.1M to $1.2M, and total capital declined 12.57% from $20.01M to $17.49M.
NASDAQ
04/04/2025 12:55PM Eastern
Quotes delayed
